Pruritus and Aromatherapy Associated with Chronic Kidney Disease

Öz

Chronic kidney disease, a common disease worldwide, is characterised by persistent deterioration of kidney function. Dermatological issues such as pruritus and xerosis, frequently observed in this condition, significantly impair patients’ quality of life and complicate the treatment process. The pathophysiology of pruritus involves factors such as peripheral neuropathy, immune system imbalances, opioid receptor dysregulation, the activation of non-histaminergic itch pathways due to the accumulation of uremic toxins in the skin, microinflammation, and xerosis. In addition to pharmacological treatments, non-pharmacological methods, particularly aromatherapy, are increasingly being utilized to manage pruritus. Essential oils such as lavender, violet, chia seed oil, and many others are applied topically, through massage, or inhalation to alleviate symptoms of pruritus and xerosis. Existing literature suggests that aromatherapy may be effective in reducing skin symptoms and pruritus. However, to establish the efficacy and safety of this therapeutic approach, more comprehensive studies are required, focusing on the standardization of application protocols and the evaluation of the effectiveness of various essential oils. Assessing the effects of aromatherapy through comparative clinical trials with larger sample groups is crucial for enhancing the evidence base in this area.

Anahtar Kelimeler

• Aromatherapy
• Pruritus
• Chronic Kidney Disease

Kronik Böbrek Hastalığı ile İlişkili Kaşıntı ve Aromaterapi/ Pruritus and Aromatherapy Associated with Chronic Kidney Disease

Öz

Dünya genelinde yaygın bir hastalık olan kronik böbrek hastalığı böbrek fonksiyonlarının kalıcı olarak bozulmasıyla karakterizedir. Bu hastalıkta sıklıkla görülen dermatolojik problemler arasında yer alan kaşıntı ve cilt kuruluğu, hastaların yaşam kalitesini ciddi şekilde düşürmekte ve tedavi sürecini karmaşık hale getirmektedir. Kaşıntının patofizyolojisi; periferik nöropati, immün sistem dengesizlikleri, opioid reseptör dengesizlikleri, ciltte üremik toksin birikimine bağlı histaminerjik olmayan kaşıntı yolunun aktivasyonu, mikroinflamasyon ve kseroz gibi faktörlere dayanmaktadır. Kaşıntının yönetiminde farmakolojik tedavilere ek olarak non- farmakolojik yöntemler, özellikle aromaterapi, giderek artan bir şekilde kullanılmaktadır. Aromaterapide lavanta, menekşe, chia tohumu yağı ve daha birçok esansiyel yağ; topikal uygulama, masaj veya inhalasyon yoluyla uygulanarak kaşıntı ve kseroz semptomlarını hafifletmek amacıyla kullanılmaktadır. Mevcut literatür, aromaterapinin cilt semptomlarını ve kaşıntıyı azaltmada potansiyel olarak etkili olabileceğini göstermektedir. Ancak, bu tedavi yönteminin etkinliğini ve güvenilirliğini belirlemek için uygulama protokollerinin standardizasyonu ve esansiyel yağların etkililiğini inceleyen daha kapsamlı araştırmalara ihtiyaç duyulmaktadır. Aromaterapinin etkilerinin daha geniş örneklem grupları ile karşılaştırmalı klinik çalışmalarla değerlendirilmesi, bu alandaki kanıt seviyesini artırmak açısından büyük önem taşımaktadır.

Anahtar Kelimeler

• Aromaterapi
• Kaşıntı
• Kronik Böbrek Hastalığı

Kaynakça

1. theisn.org. [Internet] International Society of Nephrology. ISN–Global Kidney Health Atlas. 2023(Internet). 2023[cited 2024 Oct 11]. Available from: www.theisn.org/global-atlas
2. hsgm.saglik.gov.tr [Internet]. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Türkiye Böbrek Hastalıkları Önleme ve Kontrol Programı. 2018[cited 2024 Oct 11]. Available from: https://hsgm.saglik.gov.tr/depo/birimler/kronik-hastaliklar-ve-yasli-sagligi db/Dokumanlar/Kitaplar/Turkiye_Bobrek_Hastaliklari_Onleme_ve_Kontrol_Programi_2018-2023.pdf
3. Varol E, Sivrikaya SK. Kronik böbrek yetmezliğinde yaşam kalitesi ve hemşirelik. J DU Health Sci Inst (Internet). 2018[cited 2024 Oct 11];8(2):89–96. Available from: https://dergipark.org.tr/tr/download/article-file/504947
4. Tayaz E, Koç A. Hemodiyaliz tedavisi alan kronik böbrek yetmezliği hastalarında semptom yönetimi ve hemşirelik. JANHS [Internet]. 2020[cited 2024 Oct 11];23(1):147–56. Available from: https://dergipark.org.tr/tr/download/article-file/1013655
5. Rashpa R, Mahajan V, Kumar P, Mehta K, Chauhan P, Rawat R, et al. Mucocutaneous manifestations in patients with chronic kidney disease: A cross-sectional study. Indian Dermatol Online J. 2018;9(1):20-6. https://doi.org/10.4103/idoj.IDOJ_160_17
6. Tajalli F, Mirahmadi SMS, Mozafarpoor S, Goodarzi A, Nasiri Partovi M, Lakestani D. Mucocutaneous manifestations of patients with chronic kidney disease under hemodialysis: A cross-sectional study of 49 patients. Dermatol Ther. 2021;34(4):e15015. https://doi.org/10.1111/DTH.15015
7. Engler F, Kerschbaum J, Keller F, Mayer G, Antlanger M, Edlinger R, et al. Prevalence, patient burden and physicians’ perception of pruritus in haemodialysis patients. Nephrol Dial Transplant. 2024;39(2):277–85. https://doi.org/10.1093/ ndt/gfad152
8. Wulczyn KE, Steele DJR. One-year pruritus trends among patients receiving hemodialysis and associated outcomes. Am J Kidney Dis. 2023;82(6):647–9. https://doi.org/10.1053/j.ajkd.2023.08.004

9. Sukul N, Karaboyas A, Csomor PA, Schaufler T, Wen W, Menzaghi F, et al. Self-reported pruritus and clinical, dialysis-related, and patient-reported outcomes in hemodialysis patients. Kidney Med. 2021;3(1):42-53. https://doi.org/10.1016/ j.xkme.2020.08.011
10. Orasan OH, Muresan F, Mot A, Sitar Taut A, Minciuna I, Coste SC, et al. Hemodialysis patients with pruritus and ınsomnia have ıncreased risk of death. Blood Purif. 2020;49(4):419–25. https://doi.org/10.1159/000505147
11. Schricker S, Kimmel M. Unravelling the pathophysiology of chronic kidney disease-associated pruritus. Clin Kidney J. 2021;14(3):23–31. https://doi.org/10.1093/ckj/sfab200
12. Lipman ZM, Paramasivam V, Yosipovitch G, Germain MJ. Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches. Clin Kidney J. 2021;14(3):16–22. https://doi.org/10.1093/ckj/sfab167
13. Hu X, Sang Y, Yang M, Chen X, Tang W. Prevalence of chronic kidney disease-associated pruritus among adult dialysis patients. Medicine. 2018;97(21):e10633. https://doi.org/10.1097/MD.0000000000010633
14. Kazak A, Özkaraman A. Üremik pruritus ve hemşirelik yönetimi. CBU-SBED. 2020;7(3):408–12. https://doi.org/10.34087/CBUSBED.695705
15. Manenti L, Leuci E. Do you feel itchy? A guide towards diagnosis and measurement of chronic kidney disease-associated pruritus in dialysis patients. Clin Kidney J. 2021;14(3):8–15. https://doi.org/10.1093/ckj/sfab143
16. Şahin A, Sarıtaş SÇ, Soylu A. Üremik kaşıntıda kullanılan tamamlayıcı sağlık yaklaşımları. NefroHemDergi. 2020;15(2):96–103. https://doi.org/10.47565/NDTHDT.2020.11
17. Kavurmacı M, Tan M. Üremik kaşıntı ve hemşirelik bakımı. Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi. 2015;18(1):57–62. https://doi.org/10.17049/AHSBD.82817
18. Cheng AY, Wong LS. Uremic pruritus: from diagnosis to treatment. Diagnostics (Basel). 2022;12(5):1108. https://doi.org/10.3390/DIAGNOSTICS12051108
19. Topf J, Wooldridge T, McCafferty K, Schömig M, Csiky B, Zwiech R, et al. Efficacy of difelikefalin for the treatment of moderate to severe pruritus in hemodialysis patients: pooled analysis of KALM-1 and KALM-2 phase 3 studies. Kidney Med. 2022;4(8):100512. https://doi.org/10.1016/j.xkme.2022.100512
20. Ko MJ, Peng YS, Wu HY. Uremic pruritus: Pathophysiology, clinical presentation, and treatments. Kidney Res Clin Pract. 2023;42(1):39–52. https://doi.org/10.23876/j.krcp.21.189
21. Krismi A, Danarti R, Setiabudi IIDPP, Wirohadidjojo YW. Chronic kidney disease‐associated pruritus in patients undergoing hemodialysis: Xerosis and topical therapy. Hemodialysis International. 2023;27(2):91–104. https://doi.org/10.1111/hdi.13071
22. Chu SWF, Ng WJ, Yeam CT, Khan RQ, Low LL, Quah JHM, et al. Manipulative and body-based methods in chronic kidney disease patients: A systematic review of randomized controlled trials. Complement Ther Clin Pract. 2022;48(2022):101593. https://doi.org/10.1016/j.ctcp.2022.101593
23. Świerczyńska K, Białynicki-Birula R, Szepietowski JC. Chronic intractable pruritus in chronic kidney disease patients: prevalence, impact, and management challenges—a narrative review. Ther Clin Risk Manag. 2021;17:1267–82. https://doi.org/10.2147/TCRM.S310550
24. Lu PH, Chuo HE, Chiu LY, Lai CC, Wang JY, Lu PH. Comparative efficacy of acupuncture point stimulation treatments for dialysis patients with uremic pruritus: a systematic review and network meta-analysis. Front Neurol. 2024;15:1342788. https://doi.org/10.3389/fneur.2024.1342788
25. Shabi I, Aboudar Z, Sidki M, Amal S, Hocar O, Aboudourib M, et al. Effectiveness of narrowband ultraviolet light in chronic kidney disease-associated pruritus. Cureus. 2024;16(1):e53340. https://doi.org/10.7759/cureus.53340
26. Lin J, Chen C, Huang C, Lai F, Wang C. Effects of an ice roller on chronic kidney disease‐associated pruritus in patients receiving haemodialysis. J Ren Care. 2024:1–12. https://doi.org/10.1111/jorc.12491
27. Alqahtani S, Bakhamees BH, Almalki FM, Alshaer AB, Altaymani AF, Alazmi MM, et al. Efficacy and safety of omega-3 fatty acids in ameliorating pruritus in adult patients with chronic kidney disease: a meta-analysis of randomized controlled trials. Cureus. 2024;16(8):e66452. https://doi.org/10.7759/cureus.66452
28. Verma V, Lamture Y, Ankar R. Management of uremic xerosis and chronic kidney disease (ckd)-associated pruritus (ckd-ap) with topical preparations: a systematic review and ımplications in the ındian context. Cureus. 2023;15(7):e42587. https://doi.org/10.7759/CUREUS.42587
29. Shah P. Essential oils: How safe? How effective?. J Fam Pract. 2023;72(9):374–81. https://doi.org/10.12788/jfp.0672
30. naha.org [Internet]. National Association for Holistic Aromatherapy. Exploring Aromatherapy | NAHA. 2024[cited 2024 Oct 11]. Available from: https://naha.org/explore-aromatherapy/about-aromatherapy/what-is-aromatherapy/
31. Hedigan F, Sheridan H, Sasse A. Benefit of inhalation aromatherapy as a complementary treatment for stress and anxiety in a clinical setting - a systematic review. Complement Ther Clin Pract. 2023;52:101750. https://doi.org/10.1016/j.ctcp.2023.101750
32. Shaki Z, Ghaffari F, Alijaniha F, Kamalinejad M, Kazemnejad A, Daneshfard B, et al. Effect of dill (anethum graveolens) oil on pruritus and quality of life of hemodialysis patients: a randomized double-blind three-arm controlled trial. Evid Based Complement Alternat Med. 2024;2024(1):3077603. https://doi.org/10.1155/2024/3077603
33. Ghazanfari SM, Mirmoosavi SJ, Jamali J, Motavasselian M, Salari R. Inflammatory bio-marker changes in hemodialysis patients with pruritus receiving violet oil: A randomized controlled trial. J Herb Med. 2022;32:100538. https://doi.org/10.1016/j.hermed.2022.100538
34. Abbasi M, Shahrbabaki PM, Jahani Y, Mehdipour-Rabori R. The effect of topical chia oil and coconut oil on pruritus and laboratory parameters in hemodialysis patients. Evidence Based Care. 2022;12(3):56–63. https://doi.org/10.22038/ ebcj.2022.63945.2658
35. Sembiring F, Nasution SS, Ariani Y. The effects of topical peppermint aromatherapy on reducing uremic pruritus in chronic kidney disease patients undergoing hemodialysis. JKS [Internet]. 2021[cited 2024 Oct 11];16(1):31-6. Available from: http://jks.fikes.unsoed.ac.id/index.php/jks/article/view/1273
36. Menekli T, Çevik Durmaz Y. Effect of lavender aromatherapy on pruritus, anxiety, and sleep quality of patients undergoing hemodialysis: a randomized controlled trial. TMR Integrative Nursing. 2021;5(5):163–9. https://doi.org/10.53388/ TMRIN2021163169
37. Muliani R, Vitniawati V, Rakhman DA. Effectiveness of olive oil with virgin coconut oil on pruritus grade scores among hemodialysis patients. IJALSR. 2021;4(4):25–33. https://doi.org/10.31632/ijalsr.2021.v04i04.004
38. Saodah S, Budi Putra I, Trisa S C. The effect of virgin coconut oil (vco) with lotion on the skin moisture among uremic patients undergoing hemodialysis in Hospital Binjai City, Indonesia. IJNHS. 2020;3(5):560–8. https://doi.org/10.35654/ijnhs.v3i5.319
39. Khorsand A, Salari R, Noras MR, Saki A, Jamali J, Sharifipour F, et al. The effect of massage and topical violet oil on the severity of pruritus and dry skin in hemodialysis patients: A randomized controlled trial. Complement Ther Med. 2019;45:248–53. https://doi.org/10.1016/j.ctim.2019.06.015
40. Sadeghnejad Z, Karampourian A, Borzou SR, Gholyaf M, Mohammadi Y, Hadadi R. The effect of ostrich oil as a complementary medicine on the severity of pruritus and quality of life in hemodialysis patients. Complement Med Res. 2021;28(1):40–5. https://doi.org/10.1159/000508288
41. Khoirot RM, Kusnanto K, Suprajitno S. Effect of topical aromatherapy turmeric oil to pruritus scale on chronic kidney disease patients. Jurnal Ners Dan Kebidanan (Journal of Ners and Midwifery). 2019;6(3):396–400. https://doi.org/10.26699/jnk. v6i3.ART.p396-400
42. Mehri Z, Afrasiabifar A, Hosseini N. Improved ıtchy quality of life following topical application of sweet almond oil in patients with uremic pruritus: a randomized, controlled trial. Jundishapur J Chronic Dis Care. 2018;7(2):e68164. https://doi.org/10.5812/jjcdc.68164
43. Abdelghfar SZ, Elsebae HA, Elhadry SM, Hassan AA. Effect of aromatherapy on uremic pruritus among patients undergoing hemodialysis. IOSR-JNHS. 2017;6(2):22–30. https://doi.org/10.9790/1959-0602082230
44. Ibrahim IM, Elsaie ML, Almohsen AM, Mohey‐Eddin MH. Effectiveness of topical clove oil on symptomatic treatment of chronic pruritus. J Cosmet Dermatol. 2017;16(4):508–11. https://doi.org/10.1111/jocd.12342
45. Afrasiabifar, A., Mehri, Z., Hosseini, N. Efficacy of topical application of sweet almond oil on reducing uremic pruritus in hemodialysis patients: a randomized clinical trial study. IRCMJ [Internet]. 2017[cited 2024 Dec 11];19(2):1-7. https://ircmj.com/article_194837.html
46. Akrami R, Hashempur MH, Tavakoli A, Nimrouzi M, Sayadi M, Roodaki M, et al. Effects of Fumaria parviflora L on uremic pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled trial. JJNPP [Internet]. 2016[cited 2024 Dec 11];12(3):e39744. https://brieflands.com/articles/jjnpp-55320.pdf
47. Elsaie L, El Mohsen A, Ibrahim I, Mohey-Eddin M, Elsaie M. Effectiveness of topical peppermint oil on symptomatic treatment of chronic pruritus. Clin Cosmet Investig Dermatol. 2016;9(2016):333–8. https://doi.org/10.2147/CCID.S116995
48. Cürcani M, Tan M. The effect of aromatherapy on haemodialysis patients’ pruritus. J Clin Nurs. 2014;23(23-24):3356–65. https://doi.org/10.1111/jocn.12579